Cerity Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,971
| Closed | -$274K | – | 1183 |
|
|
2022
Q1 | $274K | Sell |
5,971
-1,034
| -15% | -$47.4K | ﹤0.01% | 758 |
|
|
2021
Q4 | $429K | Buy |
7,005
+43
| +0.6% | +$2.63K | 0.01% | 639 |
|
|
2021
Q3 | $520K | Buy |
6,962
+67
| +1% | +$5K | 0.01% | 455 |
|
|
2021
Q2 | $638K | Sell |
6,895
-910
| -12% | -$84.2K | 0.01% | 428 |
|
|
2021
Q1 | $693K | Buy |
7,805
+918
| +13% | +$81.5K | 0.02% | 390 |
|
|
2020
Q4 | $642K | Buy |
+6,887
| New | +$642K | 0.02% | 368 |
|